Hennion & Walsh Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.44M	Buy	153,150 +6,684	+5%	+$62.7K	0.06%	397
2025 Q1	$1.04M	Buy	146,466 +25,469	+21%	+$181K	0.05%	464
2024 Q4	$1.41M	Buy	120,997 +67,276	+125%	+$784K	0.06%	380
2024 Q3	$1.1M	Buy	53,721 +13,839	+35%	+$284K	0.05%	428
2024 Q2	$893K	Buy	+39,882	New	+$893K	0.05%	449